Overall Score

Growth

Revenue growth is not provided in the fresh metrics, but the business still screens as a moderate long-term grower based on profitability and cash generation.

Free cash flow yield remains solid at 8.1%, supporting reinvestment and shareholder returns.

Profitability

Margins remain strong, with gross margin at 62.3%, EBIT margin at 42.3%, and EBITDA margin at 51.6%.

Returns are positive but modest, with ROE at 3.6%, ROIC at 2.7%, and ROA at 0.9%.

Financial Health

Leverage remains elevated, with net debt to EBITDA at 20.2x and debt to equity at 2.8x.

Liquidity is very weak, with a current ratio of 0.10 and a cash ratio of 0.04.

Valuation

Valuation is mixed: price to sales is 3.35x and price to free cash flow is 12.4x, which is reasonable for a profitable business.

The stock trades below book value at 0.88x price to book, partially offsetting the leverage risk.

Durability

The business shows durable operating margins, but the balance sheet is stretched and interest coverage is only 0.82x.

Dividend payout ratio is above 2.2x, which raises questions about long-term payout sustainability.